Pfizer &amp; @BioNTech_Group announce completion of dosing for 1st cohort of Phase 1/2 trial of Covid-19 vaccine candidates in Germany. Dosing began on 4/23. 1st vaccine trial in Germany. They plan to initiate US trials upon regulatory approval https://t.co/wMyPZiYw1e $PFE $BNTX